ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664161 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664161; 2) Community: the network communities that were significantly associated with the response to NSC 664161; 3) Molecule: the relationships between components within communities and NSC 664161; 4) MDR: the compounds that were significantly associated with the NSC 664161.

NSC Compound Enrichment Correlation
NSC 699168 Null 0.0187206825450445 0.16992651
NSC 702348 Null 0.0187206825450445 -0.077243344
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.0187206825450445 -0.047824284
NSC 757306 Pyrimethamine (USAN) 0.0187206825450445 -0.0043592643
NSC 758664 Sirolimus [USAN] 0.0187206825450445 -0.067285686
NSC 94600 Camptothecin 0.0187206825450445 0.079691285
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0187206825450448 0.024408864
NSC 348894 Benzenesulfonamide, 4-[(9-acridinylmethyl)amino]-N-(aminoiminomethyl)- 0.0187206825450448 0.19171846
NSC 382035 2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- 0.0187206825450448 0.015651842
NSC 382046 Null 0.0187206825450448 0.11839499
Total:48  Current:20    [First] [Prev] [Next] [Last]